BANVİT BANDIRMA VİTAMİNLİ YEM SANAYİ A.Ş. Özel Durum Açıklaması (Genel) 12 Mart 2026

Within the scope of the provisions of the Corporate Governance Communiqué (II-17.1) issued by the Capital Markets Board of Turkey ("CMB"), as a result of our application submitted to the CMB requesting its favourable opinion pursuant to Article 4.3.7 of the Communiqué in order to present Meral Kurdaş, Bilgün Gürkan and Demet Özdemir for the approval of the General Assembly as Independent Board Member Candidates at the first forthcoming General Assembly meeting; the CMB has notified us that it has no adverse opinion regarding the Independent Board Member candidates.

Accordingly, Meral Kurdaş, Bilgün Gürkan and Demet Özdemir will be submitted to the approval of the General Assembly as independent members at the first General Assembly meeting to be held.

Respectfully announced to the public.

This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.

We hereby declare that our above disclosures are in compliance with the principles set forth in the Capital Markets Board's Communiqué on Material Events in force, that they fully reflect the information we have received on this matter(s), that the information is in accordance with our ledgers, records and documents, that we have made all necessary efforts to obtain complete and accurate information on the subject, and that we are responsible for these disclosures.